When Will Cannabis Be Federally Legal?

Federal cannabis legalization remains one of the most closely watched policy questions in the United States, with significant implications for the cannabis industry and investors. While public support for legalization consistently polls above 65%, the legislative path forward has proven challenging due to political complexities, competing priorities, and disagreements over regulatory frameworks.

The most immediate federal reform is the rescheduling process initiated by the Biden administration in 2023, when the Department of Health and Human Services recommended moving cannabis from Schedule I to Schedule III. The DEA has been conducting its own review and rulemaking process. If completed, rescheduling would not make cannabis "legal" in the traditional sense — it would still be a controlled substance — but it would eliminate Section 280E tax burdens, enable certain types of medical research, and potentially open pathways for FDA-approved cannabis medicines.

On the legislative front, several approaches have been proposed. Comprehensive legalization bills like the Cannabis Administration and Opportunity Act (CAOA) seek to fully deschedule cannabis and create a federal regulatory framework, but these face significant opposition from lawmakers concerned about public safety and the pace of change. More incremental approaches like the SAFE Banking Act, which would simply protect banks from federal penalties for serving cannabis businesses, have garnered broader bipartisan support but have repeatedly stalled in the Senate despite passing the House multiple times.

Most cannabis industry analysts and lobbyists expect federal reform to occur incrementally rather than through a single sweeping legalization bill. The most likely sequence is: rescheduling to Schedule III first (removing 280E), followed by some form of banking reform (SAFE Banking or similar legislation), and eventually more comprehensive reform that addresses interstate commerce, social equity, and federal licensing. The timeline for this progression is uncertain but could span several years.

For cannabis investors, the federal legalization timeline is arguably the single most important variable. Each incremental step — rescheduling, banking reform, exchange uplisting — represents a distinct catalyst that could drive significant stock appreciation. However, the repeated delays and false starts in federal reform have taught seasoned cannabis investors to focus on companies with strong enough fundamentals to survive without federal change, rather than betting everything on a political timeline.